Hypoglycaemia/Hyperinsulinism
Novel Therapies for the Inhibition of Insulin Release

Investigator:

Mark Dunne (PI), mark.j.dunne@manchester.ac.uk

Summary:

Funded by Innovate UK, this grant was awarded to the University of Manchester and Heptares Therapeutics to develop new molecules for the treatment of Congenital Hyperinsulinism.

Start Date: --/--/---
End Date: July 2018

Further Information

 

Continuous Glucose Monitoring for Phenotyping of Congential Hyperinsulism

Investigator:

Mark Dunne (PI), mark.j.dunne@manchester.ac.uk

Indi Banerjee, indi.banerjee@manchester.ac.uk

Summary:

Funded by a MRC product innovation award to develop new therapeutic strategies for the treatment of Congenital Hyperinsulinism

Start Date: --/--/---
End Date: Sept 2018
Further Information: 

   

Islet Cell Biology and Hypoglycaemia

Investigator:

Mark Dunne (PI), mark.j.dunne@manchester.ac.uk

Summary:

Funded partly by Million Dollar Bike Ride Fund and Diabetes UK to investigate pathobiology of Congenital Hyperinsulinism

Start Date: --/--/---
End Date: June 2018
Further Information: